semaglutide news november 28 2025 Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least once Wegovy maker Novo Nordisk makes

Americans are relying on this technicality to get hold of all kinds of drugssome that, like Vyleesi, are supposed to require a prescription and others that arent even approved in the United States at all

Foundayo (oral non-peptide) has 2040% bioavailability significantly better than oral semaglutide (Wegovy pill/Rybelsus at ~1%) because orforglipron is a small molecule, not a fragile peptide

People in rural or remote areas If you live far from your pharmacy or in a rural area where delivery times are longer, your medication spends more time in transit and more time exposed to outdoor temperatures

A 2025 IV safety pilot in 2 healthy adults found no adverse events [PMID: 40131143], though this sample size is too small to establish safety

The proactive approach involves a synergy between being well-informed, adapting daily practices, and relying on trusted healthcare providers for adjustments when needed